Skip to main content
Top

Drugs

Issue 2/2019

Content (10 Articles)

Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options

Nicolas Collongues, Estelle Ayme-Dietrich, Laurent Monassier, Jérôme de Seze

Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke

Andrea Santamato, Nicoletta Cinone, Francesco Panza, Sara Letizia, Luigi Santoro, Madia Lozupone, Antonio Daniele, Alessandro Picelli, Alessio Baricich, Domenico Intiso, Maurizio Ranieri

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019

A. D. Pranger, T. S. van der Werf, J. G. W. Kosterink, J. W. C. Alffenaar

Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes

Sudesna Chatterjee, Kamlesh Khunti, Melanie J. Davies

Brexpiprazole: A Review in Schizophrenia

James E. Frampton

Larotrectinib: First Global Approval

  • AdisInsight Report

Lesley J. Scott

Glasdegib: First Global Approval

Sheridan M. Hoy

Fexinidazole: First Global Approval

Emma D. Deeks

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images